WS Data Solutions
Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Sell
Exponential Moving Average
Sell
Relative Strength Index
Neutral
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Sell
Wall Street Data Solutions Rating
Neutral
B
Invivyd, Inc. Common Stock (IVVD)
Biological Products, (no Disgnostic Substances)
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
1601 TRAPELO ROAD, SUITE 178
WALTHAM, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/06/2021
Market Cap
118,439,679
Shares Outstanding
110,120,000
Weighted SO
110,114,960
Total Employees
N/A
Upcoming Earnings
08/08/2024
Similar Tickers
Beta
0.6630
Last Div
0.0000
Range
0.96-5.195
Chg
-0.0484
Avg Vol
559946
Mkt Cap
118439679
Exch
NASDAQ
Country
US
Phone
781 819 0080
DCF Diff
-0.8274
DCF
1.8121
Div Yield
0.0000
P/S
22.3978
EV Multiple
0.1343
P/FV
0.8416
Div Yield %
0.0000
P/E
-0.5807
PEG
-0.0350
Payout
0.0000
Current Ratio
4.7137
Quick Ratio
4.5684
Cash Ratio
4.0290
DSO
243.4484
DIO
905.3698
Op Cycle
1148.8181
DPO
1273.0860
CCC
-124.2679
Gross Margin
0.5934
Op Margin
-40.7995
Pretax Margin
-38.5471
Net Margin
-38.5471
Eff Tax Rate
-0.0225
ROA
-1.1494
ROE
-1.0972
ROCE
-1.5340
NI/EBT
1.0000
EBT/EBIT
0.9448
EBIT/Rev
-40.7995
Debt Ratio
0.0038
D/E
0.0048
LT Debt/Cap
0.0000
Total Debt/Cap
0.0048
Int Coverage
-57.5328
CF/Debt
-273.7225
Equity Multi
1.2610
Rec Turnover
1.4993
Pay Turnover
0.2867
Inv Turnover
0.4032
FA Turnover
2.0705
Asset Turnover
0.0298
OCF/Share
-1.5617
FCF/Share
-1.5628
Cash/Share
1.2389
OCF/Sales
-35.2506
FCF/OCF
1.0008
CF Coverage
-273.7225
ST Coverage
-273.7225
CapEx Coverage
-1331.4643
Div&CapEx Cov
-1331.4643
P/BV
0.8416
P/B
0.8416
P/S
22.3978
P/E
-0.5807
P/FCF
-0.6349
P/OCF
-0.6350
P/CF
-0.6350
PEG
-0.0350
P/S
22.3978
EV Multiple
0.1343
P/FV
0.8416
DPS
0.0000